Lipid and phospholipid composition of the inner mitochondrial membrane of hepatocytes under conditions of glutamate-induced steatohepatosis and correction with nanocrystalline cerium dioxide
Abstract
The problem of studying the mechanisms of steatohepatosis development and its correction remains relevant, despite the significant number of scientific studies on the pathogenesis of metabolic-associated fatty liver disease. This is confirmed by the increase in morbidity, which may be associated with a wide range of factors that cause liver steatosis and the lack of effective therapeutic and preventive agents. The study aims to establish the lipid and phospholipid composition of the inner mitochondrial membrane of rat hepatocytes under conditions of diet- and glutamate-induced steatohepatosis and to evaluate the corrective effect of nanocrystalline cerium dioxide on the formation of steatohepatosis induced by neonatal administration of monosodium glutamate. The direction of the experiments included the study of the mechanisms of development of diet- and glutamate-induced visceral obesity in 4-month-old rats and the determination of the lipid and phospholipid composition of the inner membrane of hepatocyte mitochondria in rats under conditions of high-calorie diet and after neonatal administration of monosodium glutamate against the background of periodic administration of nanocrystalline cerium dioxide. It was established that rats that were on a high-calorie diet with a high content of fats, carbohydrates, and a reduced content of proteins for 4 months, and rats that were administered monosodium glutamate in the neonatal period, develop ed visceral obesity without the manifestation of hyperphagia, characterized by dyslipidemia and the development of steatohepatosis. A feature of the development of diet- and glutamate-induced steatohepatosis is mitochondrial dysfunction, which is characterized by changes in the lipid and phospholipid composition of the inner membrane of hepatocyte mitochondria. Not only structural changes occur in the membrane, but also dysfunctional changes in the mitochondria as a whole, manifesting themselves in the fact that ROS are generated in the respiratory chain instead of ATP, and this causes the development of oxidative stress in both the mitochondria and the entire hepatocyte. Periodic administration of nanocrystalline cerium dioxide to rats with glutamate-induced steatohepatosis significantly restore d the lipid and phosph o lipid composition of the inner membrane of hepatocyte mitochondria, reduce d manifestations of oxidative stress, and reduce d the content of oxidized forms of phosphatidylcholine and phosphatidylethanolamine in the inner membrane of hepatocyte mitochondria against the background of normalization of cardiolipin content, which indicates the antioxidant effect of this drug and the possibility of its use for the prevention of steatohepatosis.References
Angulo, P., Kleiner, D. E., Dam-Larsen, S., Adams, L. A., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Keach, J. C., Lafferty, H. D., Stahler, A., Haflidadottir, S., & Bendtsen, F. (2015). Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology, 149(2), 389–397.
Aoun, M., Feillet-Coudray, C., Fouret, G., Chabi, B., Crouzier, D., Ferreri, C., Chatgilialoglu, C., Wrutniak-Cabello, C., Cristol, J. P., Carbonneau, M. A., & Coudray, C. (2012). Rat liver mitochondrial membrane characteristics and mitochondrial functions are more profoundly altered by dietary lipid quantity than by dietary lipid quality: Effect of different nutritional lipid patterns. The British Journal of Nutrition, 107(5), 647–659.
Ardail, D., Privat, J. P., Egret-Charlier, M., Levrat, C., Lerme, F., & Louisot, P. (1990). Mitochondrial contact sites. Lipid composition and dynamics. The Journal of Biological Chemistry, 265(31), 18797–18802.
Balducci, S. (2020). Prevention of type 2 diabetes by physical activity: What has history taught us? Diabetes/Metabolism Research And Reviews, 36(5), e3308.
Bernardis, L. L., & Patterson, B. D. (1968). Correlation between “Li index” and carcass fat content in weanling and adult female rats with hypothalamic lessions. Journal of Endocrinology, 40, 527–528.
Bieganski, R. M., & Yarmush, M. L. (2011). Novel ligands that target the mitochondrial membrane protein mitoNEET. Journal of Molecular Graphics and Modelling, 29(7), 965–973.
Bonomini, F., Rodella, L. F., & Rezzani, R. (2015). Metabolic syndrome, aging and involvement of oxidative stress. Aging and Disease, 6(2), 109–120.
Breslow, D. K., & Weissman, J. S. (2010). Membranes in balance: Mechanisms of sphingolipid homeostasis. Molecular Cell, 40(2), 267–279.
Broekhuyse, R. M. (1968). Phospholipids in tissues of the eye. I. Isolation, characterization and quantitative analysis by two-dimensional thin-layer chromatography of diacyl and vinyl-ether phospholipids. Biochimica et Biophysica Acta, 152(2), 307–315.
Caputo, F., Mameli, M., Sienkiewicz, A., Licoccia, S., Stellacci, F., Ghibelli, L., & Traversa, E. (2017). A novel synthetic approach of cerium oxide nanoparticles with improved biomedical activity. Scientific Reports, 7(1), 4636.
Folch, J., Lees, M., & Sloane Stanley, G. H. (1957). A simple method for the isolation and purification of total lipides from animal tissues. The Journal of Biological Chemistry, 226(1), 497–509.
Goh, G. B., Pagadala, M. R., Dasarathy, J., Unalp-Arida, A., Sargent, R., Hawkins, C., Sourianarayanane, A., Khiyami, A., Yerian, L., Pai, R. K., Dasarathy, S., & McCullough, A. J. (2014). Clinical spectrum of non-alcoholic fatty liver disease in diabetic and non-diabetic patients. BBA Clinical, 3, 141–145.
Gonçalves, I. O., Maciel, E., Passos, E., Torrella, J. R., Rizo, D., Viscor, G., Rocha-Rodrigues, S., Santos-Alves, E., Domingues, M. R., Oliveira, P. J., Ascensão, A., & Magalhães, J. (2014). Exercise alters liver mitochondria phospholipidomic profile and mitochondrial activity in non-alcoholic steatohepatitis. The International Journal of Biochemistry and Cell Biology, 54, 163–173.
Gutyj, B. V., Martyshuk, T. V., Parchenko, V. V., Kaplaushenko, A. H., Bushueva, I. V., Hariv, I. I., Bilash, Y. P., Brygadyrenko, V. V., Turko, Y. I., & Radzykhovskyi, M. L. (2022). Effect of liposomal drug based on interferon and extract from Silybum marianum on antioxidative status of bulls against the background of contamination of fodders by cadmium and plumbum. Regulatory Mechanisms in Biosystems, 13(4), 419–425.
Hernández Bautista, R. J., Mahmoud, A. M., Königsberg, M., & López Díaz Guerrero, N. E. (2019). Obesity: Pathophysiology, monosodium glutamate-induced model and anti-obesity medicinal plants. Biomedicine and Pharmacotherapy, 111, 503–516.
Horvath, S. E., & Daum, G. (2013). Lipids of mitochondria. Progress in Lipid Research, 52(4), 590–614.
Hwang, S. G., Jung, E. M., Oh, S. W., Kwon, C. I., Kim, K. C., Hong, S. P., Park, P. W., & Rim, K. S. (2001). Freezing and thawing conditions of rat hepatocytes. Korean Journal of Hepatology, 7(3), 308–314.
Kobyliak, N., Abenavoli, L., Kononenko, L., Kyriienko, D., & Spivak, M. (2019). Neuropathic diabetic foot ulcers treated with cerium dioxide nanoparticles: A case report. Diabetes and Metabolic Syndrome, 13(1), 228–234.
Kondro, M. M., Verveha, B. M., Gutyj, B. V., Beregova, T. V., & Spivak, M. Y. (2024). Mitochondrial dysfunction of the inner membrane of hepatocytes in the development of glutamate-induced steatohepatosis and its correction. Regulatory Mechanisms in Biosystems, 15(2), 212–218.
Kondro, М. М., Voieikova, D. О., Stepanova, L. І., Antonenko, А. V., Spivak, M. Y., & Beregova, Т. V. (2019). The phospholipid composition of internal membrane of hepatocytes in rats with glutamat-induced steatohepatitis and its correction by cerium dioxide nanoparticles. Research Journal of Pharmaceutical, Biological and Chemical Sciences, 10(2), 411–417.
Kondro, М., Mykhalchyshyn, G., Bodnar, P., Kobyliak, N., & Falalyeyeva, T. (2013). Metabolic profile and morfo-functional state of the liver in rats with glutamate-induced obesity. Wydawca Uniwersytet Medyczny w Lublinie Current Issues in Pharmacy and Medical Sciences, 4(26), 379–381.
Kong, S., & So, W. Y. (2021). Association between physical activity and obesity-related factors. Minerva Medica, 112(3), 418–420.
Lidofsky, S. D. (2008). Nonalcoholic fatty liver disease: diagnosis and relation to metabolic syndrome and approach to treatment. Current Diabetes Reports, 8(1), 25–30.
Louro, H., Saruga, A., Santos, J., Pinhão, M., & Silva, M. J. (2019). Biological impact of metal nanomaterials in relation to their physicochemical characteristics. Toxicology in Vitro, 56, 172–183.
Monteiro, J. P., Pereira, C. V., Silva, A. M., Maciel, E., Baldeiras, I., Peixoto, F., Domingues, M. R., Jurado, A. S., & Oliveira, P. J. (2013). Rapeseed oil-rich diet alters hepatic mitochondrial membrane lipid composition and disrupts bioenergetics. Archives of Toxicology, 87(12), 2151–2163.
Moridi, H., Hosseini, S. A., Shateri, H., Kheiripour, N., Kaki, A., Hatami, M., & Ranjbar, A. (2018). Protective effect of cerium oxide nanoparticle on sperm quality and oxidative damage in malathion-induced testicular toxicity in rats: An experimental study. International Journal of Reproductive Biomedicine, 16(4), 261–266.
Nakanishi, Y., Tsuneyama, K., Fujimoto, M., Salunga, T. L., Nomoto, K., An, J. L., Takano, Y., Iizuka, S., Nagata, M., Suzuki, W., Shimada, T., Aburada, M., Nakano, M., Selmi, C., & Gershwin, M. E. (2008). Monosodium glutamate (MSG): A villain and promoter of liver inflammation and dysplasia. Journal of Autoimmunity, 30(1–2), 42–50.
Okediran, B. S., Olurotimi, A. E., & Rahman, S. A. (2014). Alterations in the lipid profile and liver enzymes of rats treated with monosodium glutamate. Sokoto Journal of Veterinary Sciences, 12(3), 42–46.
Osman, C., Voelker, D. R., & Langer, T. (2011). Making heads or tails of phospholipids in mitochondria. The Journal of Cell Biology, 192(1), 7–16.
Paradies, G., Paradies, V., Ruggiero, F. M., & Petrosillo, G. (2014). Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease. World Journal of Gastroenterology, 20(39), 14205–14218.
Pessayre, D. (2007). Role of mitochondria in non-alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology, 22(S1), S20–S27.
Roberts, M. E., Crail, J. P., & Laffoon, M. M. (2013). Identification of disulfide bond formation between MitoNEET and glutamate dehydrogenase 1. Biochemistry, 52(50), 8969–8971.
Rolo, A. P., Teodoro, J. S., & Palmeira, C. M. (2012), Role of oxidative stress in pathogenesis of nonalcoholic steatohepatitis. Free Radical Biology and Medicine, 52(1), 59–69.
Savcheniuk, O., Kobyliak, N., Kondro, M., Virchenko, O., Falalyeyeva, T., & Beregova, T. (2014). Short-term periodic consumption of multiprobiotic from childhood improves insulin sensitivity, prevents development of non-alcoholic fatty liver disease and adiposity in adult rats with glutamate-induced obesity. BMC Complementary and Alternative Medicine, 14, 247.
Verveha, B. M., Gutyj, B. V., Lishchuk, S. H., Holubiev, M. I., & Mylostyvyi, R. V. (2023). Oxidative modification of proteins and antioxidant status in blood of the rats with experimental acute generalized peritonitis against the background of streptozotocin-induced diabetes. Regulatory Mechanisms in Biosystems, 14(2), 260–265.
Vial, G., Dubouchaud, H., Couturier, K., Cottet-Rousselle, C., Taleux, N., Athias, A., Galinier, A., Casteilla, L., & Leverve, X. M. (2011). Effects of a high-fat diet on energy metabolism and ROS production in rat liver. Journal of Hepatology, 54(2), 348–356.
Voieikova, D., Stepanova, L., Beregova, T., Ostapchenko, L., & Kondro, M. (2016). Phospholipid composition in the inner mitochondrial membrane of rat hepatocytes under the developing of different types of steatohepatosis. Bulletin of Taras Shevchenko National University of Kyiv, Series: Problems of Physiological Functions Regulation, 20, 30–33.
Wei, Y., Rector, R. S., Thyfault, J. P., & Ibdah, J. A. (2008). Nonalcoholic fatty liver disease and mitochondrial dysfunction. World Journal of Gastroenterology, 14(2), 193–199.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons «Attribution» 4.0 License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
